Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Accepts healthy volunteers

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

ClinicalTrials.gov ID: NCT04199689

Public ClinicalTrials.gov record NCT04199689. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, International, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Efficacy, Immunogenicity, and Safety of the 9vHPV Vaccine, a Multivalent L1 Virus-like Particle Vaccine, in the Prevention of Oral Persistent Infection With HPV Types 16, 18, 31, 33, 45, 52, or 58 in Adult Males, 20 to 45 Years of Age

Study identification

NCT ID
NCT04199689
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
6,033 participants

Conditions and interventions

Interventions

  • 9vHPV Vaccine Biological
  • Placebo (Saline for Injection) Other

Biological · Other

Eligibility (public fields only)

Age range
20 Years to 45 Years
Sex
Male
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 26, 2020
Primary completion
Aug 26, 2027
Completion
Aug 30, 2028
Last update posted
Mar 24, 2025

2020 – 2028

United States locations

U.S. sites
32
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Valley Clinical Trials Inc. ( Site 0002) Northridge California 91325
Inland Empire Clinical Trials, LLC ( Site 0025) Rialto California 92377
Alta California Medical Group ( Site 0031) Simi Valley California 93065
Encompass Clinical Research ( Site 0028) Spring Valley California 91978
Diablo Clinical Research, Inc ( Site 0042) Walnut Creek California 94598
Clinical Research of South Florida ( Site 0036) Coral Gables Florida 33134
Acevedo Clinical Research Associates ( Site 0001) Miami Florida 33142
Moffitt Cancer Center ( Site 0017) Tampa Florida 33617
Augusta University ( Site 0010) Augusta Georgia 30912
Solaris Clinical Research, LLC ( Site 0003) Meridian Idaho 83646
Cotton-O'Neil Clinical Research Center ( Site 0044) Topeka Kansas 66606
Heartland Research Associates, LLC ( Site 0034) Wichita Kansas 67207
Kentucky Pediatric/Adult Research Inc ( Site 0011) Bardstown Kentucky 40004
Healthcare Research Network LLC ( Site 0035) Hazelwood Missouri 63042
Alliance for Multispecialty Reseach, LLC ( Site 0021) Las Vegas Nevada 89119
Certified Research Associates ( Site 0041) Cortland New York 13045
Laser Surgery Care ( Site 0018) New York New York 10011
Weill Cornell Medicine ( Site 0046) New York New York 10065
Rochester Clinical Research, Inc. ( Site 0008) Rochester New York 14609
PMG Research of Salisbury ( Site 0009) Salisbury North Carolina 28144
Rapid Medical Research, Inc. ( Site 0037) Cleveland Ohio 44122
Preferred Primary Care Physicians ( Site 0032) Pittsburgh Pennsylvania 15236
Coastal Carolina Research Center ( Site 0043) North Charleston South Carolina 29405
Holston Medical Group ( Site 0030) Kingsport Tennessee 37660
University of Texas Medical Branch at Galveston ( Site 0038) Galveston Texas 77555-1115
Texas Center For Drug Development ( Site 0013) Houston Texas 77081
Crossroads Clinical Research LLC ( Site 0027) Victoria Texas 77901
J Lewis Research Inc/Foothill Family Clinic South ( Site 0006) Salt Lake City Utah 84121
J Lewis Research Inc/Jordan River Family Medicine ( Site 0023) South Jordan Utah 84095
Charlottesville Medical Research Center, LLC ( Site 0007) Charlottesville Virginia 22911
Health Research of Hampton Roads, Inc. ( Site 0015) Newport News Virginia 23606
Clinical Research Partners, LLC. ( Site 0004) Richmond Virginia 23226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04199689, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 24, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04199689 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →